Headline
The latest stories from AHA Today.
The FBI today alerted the private sector to a sophisticated and aggressive nation-state campaign targeting known critical and common vulnerabilities in virtual private networks, initially reported by the government last year.
The AHA issued a Regulatory Advisory with a summary of the July 31 Centers for Medicare & Medicaid Services’ final rule for the inpatient psychiatric facility prospective payment system for fiscal year 2021.
The National Academies of Sciences, Engineering, and Medicine will host webinars on crisis standards of care and COVID-19 data applications for state and local decision-making during the pandemic.
The Centers for Medicare & Medicaid Services resumed the five-state Review Choice Demonstration for Home Health Services, ending a pause initiated March 29 due to the COVID-19 pandemic.
The National Institutes of Health’s Rapid Acceleration of Diagnostics initiative awarded $248.7 million in contracts to produce four new laboratory tests and three new point-of-care tests to detect SARS-CoV-2.
The Department of Health and Human Services extended to Aug. 28 the deadline for eligible Medicaid, Children’s Health Insurance Program and dental providers to apply for $15 billion in Provider Relief Funds available through the Phase 2 general distribution to these providers.
In this two-part Trustee Insights podcast, senior health leaders discuss challenges board members can expect to encounter as they strive for health equity and how best to meet them.
The AHA’s American Society for Health Care Risk Management this month released the second in a series of white papers for providers managing patients with behavioral health disorders beyond the inpatient setting.
The House of Representatives voted 217-197 to approve six appropriations bills, including legislation that would provide $196.5 billion in funding for the departments of Labor, Health and Human Services, and Education in fiscal year 2021.
The Centers for Medicare & Medicaid Services seeks input on rulemaking to require electronic prescribing for controlled substances covered by Medicare Part D and Medicare Advantage prescription drug plans beginning Jan. 1, in accordance with the Substance Use-Disorder Prevention that Promotes…